Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-induced thrombocytopenia

R Demasi1, A P Bode, C Knupp

  • 1Dept. of Surgery, School of Medicine, East Carolina Univ., Greenville, NC 27858-4354.

The American Surgeon
|January 1, 1994
PubMed
Summary

Heparin-induced thrombocytopenia (HIT) is a rare but serious complication of heparin therapy. Surgical patients, especially those undergoing vascular or cardiac procedures, face increased risk and severe outcomes, including mortality and amputation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Language matters: Guidance for person-centred diabetes communication in Ireland.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Impact of COVID-19 on management and outcomes of NHS patients with recurrent respiratory papillomatosis: evidence from a UK registry.

Annals of the Royal College of Surgeons of England·2025
Same author

Barriers and enablers to implementing police mental health co-responder programs: A qualitative study using the consolidated framework for implementation research.

Implementation research and practice·2024
Same author

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2023
Same author

Perspectives on paediatric sleep-disordered breathing in the UK: a qualitative study.

The Journal of laryngology and otology·2022
Same author

Behcet's Disease (BD) Presenting as a Cerebral Venous Sinus Thrombosis (CVST).

Irish medical journal·2022

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Surgical Complications

Background:

  • Heparin-induced thrombocytopenia (HIT) is a rare but severe adverse drug reaction.
  • HIT can lead to significant patient morbidity and mortality.
  • Early diagnosis and management are crucial for improving patient outcomes.

Purpose of the Study:

  • To review the clinical characteristics of patients with heparin-induced platelet aggregation.
  • To identify risk factors and outcomes associated with HIT.
  • To estimate the incidence of HIT in surgical patients.

Main Methods:

  • Retrospective review of patients referred to a specialized platelet study lab.
  • Inclusion criteria: positive in-vitro platelet aggregation assay with heparin.

Related Experiment Videos

  • Data collected: clinical characteristics, surgical history, and outcomes.

    • Main Results:

    • Ten out of 40 patients tested positive for heparin-induced platelet aggregation.
    • A majority of positive cases (8/10) were surgical patients, with 6/8 undergoing major vascular or cardiac procedures.
    • High rates of mortality (30%) and thromboembolic morbidity (80%), including amputations, were observed.

    Conclusions:

    • Heparin-induced thrombocytopenia is associated with severe morbidity and mortality.
    • Major vascular or cardiac surgery patients are at increased risk.
    • Increased awareness and vigilant platelet count monitoring in high-risk patients may mitigate adverse outcomes.